DANIEL TOD SMITHEY
Pilots at Innes Market Rd, Bend, OR
License number
Oregon A4264299
Issued Date
May 2016
Expiration Date
May 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
19009 Innes Market Rd, Bend, OR 97701
Personal information
See more information about DANIEL TOD SMITHEY at radaris.comName
Address
Phone
19009 Innes Market Rd, Bend, OR 97701
2131 Panama St, Bend, OR 97701
19009 Innes Market Rd, Bend, OR 97701
Professional information
Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material
US Patent:
2010031, Dec 9, 2010
Filed:
Dec 5, 2008
Appl. No.:
12/746754
Inventors:
Warren Kenyon Miller - Bend OR, US
Daniel Smithey - Bend OR, US
Benjamin Lee Frankamp - Redmond OR, US
Ralph Tadday - Bend OR, US
Daniel Smithey - Bend OR, US
Benjamin Lee Frankamp - Redmond OR, US
Ralph Tadday - Bend OR, US
International Classification:
A61K 9/14, A61K 31/505, A61K 31/47, A61K 31/137, A61K 31/415, A61P 43/00
US Classification:
424489, 514275, 514311, 514654, 514406, 977773, 977840, 977906
Abstract:
A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug and a poorly aqueous soluble polymer, and a resuspending material selected from the group consisting of hydroxypropyl methyl cellulose acetate succinate, carboxymethyl ethylcellulose, and pharmaceutically acceptable salt forms thereof.
Sustained Release Dosage Forms Of Ziprasidone
US Patent:
2007019, Aug 16, 2007
Filed:
Aug 31, 2004
Appl. No.:
10/931143
Inventors:
Imran Ahmed - East Lyme CT, US
Leah Appel - Bend OR, US
Walter Babcock - Bend OR, US
Dwayne Friesen - Bend OR, US
Scott Herbig - East Lyme CT, US
David Lyon - Bend OR, US
Sheri Shamblin - North Stonington CT, US
Ravi Shanker - Groton CT, US
Daniel Smithey - Bend OR, US
Steven Sutton - Niantic CT, US
Avinash Thombre - East Lyme CT, US
Kenneth Waterman - Waterfod CT, US
Leah Appel - Bend OR, US
Walter Babcock - Bend OR, US
Dwayne Friesen - Bend OR, US
Scott Herbig - East Lyme CT, US
David Lyon - Bend OR, US
Sheri Shamblin - North Stonington CT, US
Ravi Shanker - Groton CT, US
Daniel Smithey - Bend OR, US
Steven Sutton - Niantic CT, US
Avinash Thombre - East Lyme CT, US
Kenneth Waterman - Waterfod CT, US
International Classification:
A61K 9/48, A61K 31/4965
US Classification:
424451000, 514255050
Abstract:
A sustained release solid oral dosage form for treatment of a psychotic disorder, for example schizophrenia, in a mammal is provided, which oral dosage form comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.
Pharmaceutical Compositions With Enhanced Performance
US Patent:
8617604, Dec 31, 2013
Filed:
Jan 23, 2006
Appl. No.:
11/795747
Inventors:
Walter Christian Babcock - Bend OR, US
Dwayne Thomas Friesen - Bend OR, US
David Kenneth Lyon - Bend OR, US
Warren Kenyon Miller - Bend OR, US
Daniel Tod Smithey - Bend OR, US
Dwayne Thomas Friesen - Bend OR, US
David Kenneth Lyon - Bend OR, US
Warren Kenyon Miller - Bend OR, US
Daniel Tod Smithey - Bend OR, US
Assignee:
Bend Research, Inc. - Bend OR
International Classification:
A61K 9/14
US Classification:
424484, 424488
Abstract:
Pharmaceutical compositions of a low-solubility drug and lower alkanoate-, phthalate- and trimellitate esters of hydroxypropyl methyl cellulose and lower alkanoate- and succinate esters of cellulose and methyl cellulose are disclosed that provide enhanced concentrations of the drug in a use environment.
Nanoparticles Comprising A Non-Ionizable Polymer And An Anionic Cellulosic Polymer
US Patent:
2010026, Oct 21, 2010
Filed:
Jun 30, 2008
Appl. No.:
12/451812
Inventors:
Corey Jay Bloom - Bend OR, US
Marshall David Crew - Bend OR, US
Warren Kenyon Miller - Bend OR, US
Daniel Tod Smithey - Bend OR, US
Marshall David Crew - Bend OR, US
Warren Kenyon Miller - Bend OR, US
Daniel Tod Smithey - Bend OR, US
International Classification:
A61K 9/14, A61K 31/42, A61K 31/47, A61K 31/415
US Classification:
424488, 424499, 514378, 514313, 514406, 977773
Abstract:
A pharmaceutical composition comprises nanoparticles comprising a poorly water soluble drug, a poorly aqueous soluble non-ionizable polymer, and an anionic cellulosic polymer.
Pharmaceutical Compositions Of Adsorbates Of Amorphous Drug
US Patent:
2007014, Jun 28, 2007
Filed:
Dec 4, 2006
Appl. No.:
11/566408
Inventors:
Walter Babcock - Bend OR, US
Dwayne Friesen - Bend OR, US
Ravi Shanker - Groton CT, US
Daniel Smithey - Bend OR, US
Ralph Tadday - Bend OR, US
Dwayne Friesen - Bend OR, US
Ravi Shanker - Groton CT, US
Daniel Smithey - Bend OR, US
Ralph Tadday - Bend OR, US
International Classification:
A61K 33/44, A61K 9/20
US Classification:
424464000, 424125000
Abstract:
Pharmaceutical compositions comprise a low-solubility drug adsorbed onto a high surface area substrate to form an adsorbate. The compositions in some embodiments include a concentration-enhancing polymer.
Solid Dispersion Formulations And Methods Of Use Thereof
US Patent:
8591944, Nov 26, 2013
Filed:
Mar 7, 2012
Appl. No.:
13/414369
Inventors:
Mahesh V. Padval - Needham MA, US
Jeff T. Gautschi - Bend OR, US
Daniel T. Smithey - Bend OR, US
Marshall D. Crew - Bend OR, US
Abizer Harianawala - Acton MA, US
Jeff T. Gautschi - Bend OR, US
Daniel T. Smithey - Bend OR, US
Marshall D. Crew - Bend OR, US
Abizer Harianawala - Acton MA, US
Assignee:
Zalicus Pharmaceuticals Ltd. - Vancouver
International Classification:
A61K 9/10
US Classification:
424465, 424464, 424484
Abstract:
The present invention relates to formulations and methods for increasing the bioavailability of 1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one, 1-(3,3-diphenylpropanoyl)piperazine, or a salt thereof. In particular, the formulation can include one or more pharmaceutically acceptable matrix polymers to form a solid dispersion, e. g. , a spray dried dispersion or a hot melt extrusion.
Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs And Poloxamers, And Stabilizing Polymers
US Patent:
2007014, Jun 28, 2007
Filed:
Dec 20, 2004
Appl. No.:
10/596885
Inventors:
Marshall Crew - Bend OR, US
Dwayne Friesen - Bend OR, US
Warren Miller - Bend OR, US
Ravi Shanker - Groton CT, US
Daniel Smithey - Bend OR, US
Dwayne Friesen - Bend OR, US
Warren Miller - Bend OR, US
Ravi Shanker - Groton CT, US
Daniel Smithey - Bend OR, US
International Classification:
A61K 31/47, A61K 9/20, A61K 9/14
US Classification:
424464000, 424489000, 514310000, 514313000
Abstract:
Solid compositions with improved physical stability comprise an amorphous, low-solubility drug, a poloxamer, and a stabilizing polymer. The compositions provide good physical stability during storage and concentration enhancement of dissolved drug when administered to an aqueous environment of use.
Nanoparticles Comprising A Cholesteryl Ester Transfer Protein Inhibitor And Anon-Ionizable Polymer
US Patent:
2010012, May 27, 2010
Filed:
Apr 23, 2008
Appl. No.:
12/451288
Inventors:
Corey Jay Bloom - Bend OR, US
Marshall David Crew - Bend OR, US
Daniel Tod Smithey - Bend OR, US
Warren Kenyon Miller - Bend OR, US
Michael Mark Morgen - Bend OR, US
Marshall David Crew - Bend OR, US
Daniel Tod Smithey - Bend OR, US
Warren Kenyon Miller - Bend OR, US
Michael Mark Morgen - Bend OR, US
International Classification:
A61K 31/47, A61K 9/14, A61K 9/51, A61K 31/136, A61P 3/00, A61P 9/00
US Classification:
424484, 424501, 424499, 424490, 514655, 514313, 977773, 977906
Abstract:
A pharmaceutical composition comprises nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a poorly aqueous soluble non-ionizable polymer.
Nanoparticles Comprising Ionizable, Poorly Water Soluble Cellulosic Polymers
US Patent:
2010021, Aug 26, 2010
Filed:
Jun 30, 2008
Appl. No.:
12/451813
Inventors:
Corey Jay Bloom - Bend OR, US
Marshall David Crew - Bend OR, US
Dwayne T. Friesen - Bend OR, US
Warren Kenyon Miller - Bend OR, US
Michael Mark Morgen - Bend OR, US
Daniel Tod Smithey - Bend OR, US
Marshall David Crew - Bend OR, US
Dwayne T. Friesen - Bend OR, US
Warren Kenyon Miller - Bend OR, US
Michael Mark Morgen - Bend OR, US
Daniel Tod Smithey - Bend OR, US
International Classification:
A61K 9/14, A61K 47/34, A61K 47/38, A61P 43/00
US Classification:
424487, 424488, 424499, 5147724, 514781
Abstract:
A pharmaceutical composition comprises nanoparticles comprising ionizable, poorly water soluble cellulosic polymers.
Pharmaceutical Compositions Of Semi-Ordered Drugs And Polymers
US Patent:
8491933, Jul 23, 2013
Filed:
Aug 23, 2012
Appl. No.:
13/593263
Inventors:
Walter C. Babcock - Bend OR, US
William B. Caldwell - Bend OR, US
Marshall D. Crew - Bend OR, US
Dwayne T. Friesen - Bend OR, US
Ravi M. Shanker - Groton CT, US
Daniel T. Smithey - Bend OR, US
William B. Caldwell - Bend OR, US
Marshall D. Crew - Bend OR, US
Dwayne T. Friesen - Bend OR, US
Ravi M. Shanker - Groton CT, US
Daniel T. Smithey - Bend OR, US
Assignee:
Bend Research, Inc. - Bend OR
International Classification:
A61K 9/14
US Classification:
424468
Abstract:
A solid composition of a low-solubility drug and a concentration-enhancing polymer has a portion of the drug in a semi-ordered state.